Skip to main content
Premium Trial:

Request an Annual Quote

Kogene Biotech Novel Coronavirus Test Gets Regulatory Approvals in Korea

NEW YORK – Kogene Biotech said last week that it has received regulatory approval in Korea for its novel coronavirus test. The test, called the 2019 Novel Coronavirus Real-time PCR Kit, has been granted Emergency Use Assessment and Listing (EUAL) in Korea.

Specifically, the Seoul, Korea-based company has been granted EUAL from the Korea Centers for Disease Control and the Korea Food and Drug Administration. It is also the first novel coronavirus test to be granted EUAL in Korea, according to the firm.

Kogene has now ramped up production of the test to provide it to the Korea CDC as well as 50 Korean hospitals that have designated nCoV testing labs. The company is also beginning to evaluate the test in China, Japan, KSA, UAE, Iraq, Vietnam, and Bahrain.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.